← Back to catalogue

Pointe Scientific, Inc. Phosphorus

FDA UDI

Class I (US FDA UDI)

by Pointe Scientific, Inc.

Identity

Trade Name
Pointe Scientific, Inc. Phosphorus FDA UDI
Generic Name
Inorganic phosphate (PO43-) IVD, reagent FDA UDI
Device Name
Pointe Scientific, Inc. Phosphorus Reagent is for the quantitative determination of inorganic phosphorus in serum on Olympus analyzers. For in vitro diagnostic use only. 6 x 66ml, 6 x 30ml FDA UDI
Model / Reference
OP916-576 FDA UDI
Description
Pointe Scientific, Inc. Phosphorus Reagent is for the quantitative determination of inorganic phosphorus in serum on Olympus analyzers. For in vitro diagnostic use only. 6 x 66ml, 6 x 30ml FDA UDI

Identifiers

Catalog Number
OP916-576 FDA UDI
Primary DI / UDI-DI
00811727015105 FDA UDI
510(k) Number
K822470 FDA UDI
FDA Product Code
CEO FDA UDI
GMDN Term
Inorganic phosphate (PO43-) IVD, reagent FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.1580 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Inorganic phosphate (PO43-) IVD, reagent

Pointe Scientific, Inc. Phosphorus by Pointe Scientific, Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Inorganic phosphate (PO43-) IVD, reagent.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 0ffc1dbd-b04e-437a-9e14-690a9b595a28 37 fields · synced May 30, 2026